Upgrade to SI Premium - Free Trial

Tonix gets FDA alignment on Lyme disease antibody study design

August 3, 2026 7:00 AM
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced it has received official minutes from a Type C meeting with the U.S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA